Copyright
©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Cases. Oct 26, 2019; 7(20): 3282-3288
Published online Oct 26, 2019. doi: 10.12998/wjcc.v7.i20.3282
Published online Oct 26, 2019. doi: 10.12998/wjcc.v7.i20.3282
Hepatic amyloidosis leading to hepatic venular occlusive disease and Budd-Chiari syndrome: A case report
Ting-Ting Li, Yi-Fan Wu, Fu-Quan Liu, Fu-Liang He, Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, The 9th Affiliated Hospital of Peking University, Beijing 100038, China
Author contributions: Li TT and Wu YF are co-first authors; Li TT and Wu YF drafted the first manuscript; He LF and Liu FQ designed the study.
Informed consent statement: Informed written consent was obtained from the patient.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
CARE Checklist (2016) statement: The manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Corresponding author: Fu-Liang He, MD, PhD, Doctor, Department of Interventional Therapy, Beijing Shijitan Hospital, Capital Medical University, The 9th Affiliated Hospital of Peking University, Tieyi Road, No. 10, Haidian District, Beijing 100038, China. hefuliangjiayuan@163.com
Telephone: +86-10-63926269 Fax: +86-10-63925588
Received: May 17, 2019
Peer-review started: May 21, 2019
First decision: July 30, 2019
Revised: August 30, 2019
Accepted: September 9, 2019
Article in press: September 9, 2019
Published online: October 26, 2019
Peer-review started: May 21, 2019
First decision: July 30, 2019
Revised: August 30, 2019
Accepted: September 9, 2019
Article in press: September 9, 2019
Published online: October 26, 2019
Core Tip
Core tip: Transjugular intrahepatic portosystem shunt is an effective treatment for hepatic amyloidosis with hepatic venous occlusion and Budd-Chiari syndrome.